跳至主要内容
临床试验/CTRI/2025/02/081051
CTRI/2025/02/081051尚未招募2 期

Comparative clinical study to evaluate efficacy of Chagaladya ghrita with resistance exercise in sarcopenia.

DrVikrant Londhe1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年3月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1 Improvement in muscle strength . 2 Improvement in lean muscle mass.

研究概览

简要总结

The study will conducted after obtaining permission from institutional ethical community and will be regesistred CTRI india.

As per inclusion criteria patient will be selected and screening done at OPD and IPD.

Subjective and Objective parameter will be checked and noted.

Whole research procedure and aim will be clearly informed to patient hence form will be signed by enrolled participant and case report form will be filled

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
60.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patient having age between 60 yrs to 80 yrs irrespective of gender.
  • SARC F scores more than 4 by 10.

排除标准

  • Uncontrolled diabetes mellitus blood sugar levels are above recommended target ranges including an HbA1C level above 10.0percent, BSL F more than 200MG per DL , BSL PP more than 300MG per DL • Uncontrolled hypertension blood pressure that remains above the goal in spite of the concurrent use of 3 antihypertensive agents of different classes.
  • Ideally, one of the 3 agents should be a diuretic and all agents should be prescribed at optimal dose amounts.
  • • Uncontrolled thyroid disease.
  • • History of serious cerebro cardiovascular diseases , fracture during previous year, malignancy within 6 months .
  • • Arthritis, severe enough to prevent completion of the strength testing, history of joint replacement of knees or hip.

结局指标

主要结局

1 Improvement in muscle strength . 2 Improvement in lean muscle mass.

时间窗: baseline, 15th, 30th, 45th, 60th day folloup

3 Improvement in functional capacity.

时间窗: baseline, 15th, 30th, 45th, 60th day folloup

次要结局

  • Improvement in HS CRP level.(• Improvement in body circumference.)

研究者

发起方
DrVikrant Londhe
申办方类型
Other [vikrant.londhe-ayurved@bvp.edu.in]
责任方
Principal Investigator
主要研究者

Dr Vikrant Londhe

Bharati Vidyapeeth (Deemed to be University)

研究点 (1)

Loading locations...

相似试验